Heart allografts from PI3KδD910A/D910A + multiple dose CTLA4-Ig treated mice recovered at day 100 post-transplant showed much more severe chronic rejection with lymphocyte infiltration and vasculopathy (Fig. 4b). The gene discussed is CTLA4; the disease is vascular disorder.